This story was originally published Feb. 16.
The Broad Institute has joined the Illumina Genome Network and will offer its proprietary sample preparation processes for human whole-genome sequencing, Illumina said last week.
The IGN is Illumina's human whole-genome sequencing services business, and offers human whole-genome sequencing for customers through its own services lab and through partnerships with other institutes that have been certified to provide sequencing services on its instruments.
The Broad will offer sample-prep processes that enable sequencing of "challenging low input" DNA less than 500 nanograms and also from formalin-fixed, paraffin-embedded samples.
The Broad and Illumina will jointly evaluate projects to determine their suitability for the services.
"The Broad Institute's innovative sample preparation methods provide researchers with the ability to sequence samples that were previously inaccessible with existing techniques," Christian Henry, Illumina's vice president and general manager of the genomic solutions business unit, said in a statement.
Other members of the IGN include the BC Cancer Agency's Michael Smith Genome Sciences Centre, the University of Washington Department of Genome Sciences, the National Center for Genome Resources in New Mexico, the Macrogen/Genomic Medicine Institute in Korea, and Illumina's own services lab.